Evaluación de una propuesta de criterios de indicación de densitometría ósea en mujeres posmenopáusicas españolas basados en la herramienta FRAX®

2010 2005 Martínez-Aguilà, 2007, Decision rules for selecting women for bone mineral density testing: application in postmenopausal women referred to a bone densitometry unit, J Rheumatol, 34, 1307 Cadarette, 2004, The validity of decision rules for selecting women with primary osteoporosis for bone mineral density testing, Osteoporosis Int, 15, 361, 10.1007/s00198-003-1552-7 Gourlay, 2005, Performance of osteoporosis risk assessment tools in postmenopausal women aged 45-64 years, Osteoporosis Int, 16, 921, 10.1007/s00198-004-1775-2 Rud, 2005, Performance of four clinical screening tools to select peri- and early postmenopausal women for dual X-ray absorptiometry, Osteoporosis Int, 16, 764, 10.1007/s00198-004-1748-5 Chan, 2006, Validation of various osteoporosis risk indices in elderly Chinese females in Singapore, Osteoporos Int, 17, 1182, 10.1007/s00198-005-0051-4 Siris, 2004, Bone mineral density thresholds for pharmacological intervention to prevent fractures, Arch Intern Med, 164, 1108, 10.1001/archinte.164.10.1108 Black, 2001, An assessment tool for predicting fracture risk in postmenopausal women, Osteoporos Int, 12, 519, 10.1007/s001980170072 Chen, 2007, An approach for identifying postmenopausal women age 50-64 years at increased short-term risk for osteoporotic fracture, Osteoporos Int, 18, 1287, 10.1007/s00198-007-0380-6 Díez-Pérez, 2007, Prediction of absolute risk of non-spinal fractures using clinical risk factors and heel quantitative ultrasound, Osteoporos Int, 18, 629, 10.1007/s00198-006-0297-5 Vázquez Díaz, 2007, Fractura osteoporótica: valoración del riesgo en la práctica clínica, Med Clin (Barc), 129, 418, 10.1157/13110466 Nguyen, 2008, Development of prognostic nomograms for individualizing 5-year and 10-year fracture risk, Osteoporos Int, 19, 1431, 10.1007/s00198-008-0588-0 Hippisley-Cox, 2009, Predicting risk of osteoporotic fracture in men and women in England and Wales: prospective derivation and validation of QFractureScores, BMJ, 339, b4229, 10.1136/bmj.b4229 Kanis, 2005, Assessment of fracture risk, Osteoporos Int, 16, 581, 10.1007/s00198-004-1780-5 FRAX®. WHO Fracture Risk Assessment Tool [consultado 1 Dic 2011]. Disponible en: http://www.shef.ac.uk/FRAX/tool.jsp?country=4 Kanis, 2008, FRAX® and the assessment of fracture probability in men and women in the UK, Osteoporos Int, 19, 385, 10.1007/s00198-007-0543-5 González-Macías, 2012, Probability of fractures predicted by FRAX® and observed incidence in the Spanish ECOSAP Study cohort, Bone, 50, 373, 10.1016/j.bone.2011.11.006 Pfeilschifter, 2011, Regional and age-related variations in the proportions of hip fractures and major fractures among postmenopausal women: the Global Longitudinal Study of Osteoporosis in Women, Osteoporos Int Nolla, 2001, Value of clinical factors in selecting postmenopausal women with rheumatoid arthritis for bone densitometry, Ann Rheum Dis, 60, 799, 10.1136/ard.60.8.799 Fiter, 2001, A comparative study of computed digital absorptiometry and conventional dual-energy X-ray absorptiometry in postmenopausal women, Osteoporos Int, 12, 565, 10.1007/s001980170078 Nolla, 2002, Usefulness of bone densitometry in postmenopausal women with clinically diagnosed vertebral fractures, Ann Rheum Dis, 61, 73, 10.1136/ard.61.1.73 Looker, 1997, Prevalence of low femoral bone density in older US adults from NHANES III, J Bone Miner Res, 12, 1761, 10.1359/jbmr.1997.12.11.1761 Díaz Curiel, 1997, Study of bone mineral density in lumbar spine and femoral neck in a Spanish population. Multicentre Research Project on Osteoporosis, Osteoporosis Int, 7, 59, 10.1007/BF01623462 Lewiecki, 2008, International Society for Clinical Densitometry 2007 Adult and Pediatric Official Positions, Bone, 43, 1115, 10.1016/j.bone.2008.08.106 2011, Screening for osteoporosis: US preventive services task force recommendation statement, Ann Intern Med, 154, 356, 10.7326/0003-4819-154-5-201103010-00307 Tosteson, 2008, Cost-effective osteporosis treatment thresholds: the United States perspective, Osteoporos Int, 19, 437, 10.1007/s00198-007-0550-6 Compston, 2009, Guidelines for the diagnosis and management of osteoporosis in postmenopausal women and men from the age of 50 years in the UK, Maturitas, 62, 105, 10.1016/j.maturitas.2008.11.022 Azagra Ledesma, 2011, Usefulness of FRAX tool for the management of osteoporosis in the Spanish female population, Med Clin (Barc), 136, 613, 10.1016/j.medcli.2010.09.043 Stevenson, 2005, A systematic review and economic evaluation of alendronate, etidronate, risedronate, raloxifene and teriparatide for the prevention and treatment of postmenopausal osteoporosis, Health Technol Assess, 9, 1, 10.3310/hta9220 Agència d’Informació, Avaluació i Qualitat en Salut. Nota informativa sobre el uso de la versión para España de la herramienta de evaluación del riesgo de fractura FRAX [consultado 24 Abr 2012]. Disponible en: www.gencat.cat/salut/depsan/units/aatrm/pdf/nota_frax_cast.pdf